LI
Healthcare & Life Sciences

LinqMed, Inc

LinqMed, Inc is a Healthcare & Life Sciences startup based in Japan, most recent round Series B.

Activeseries-b
series-b
Stage

About LinqMed, Inc

Based in Japan, LinqMed, Inc is a startup. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences.

LinqMed, Inc develops next-generation radiopharmaceutical drugs utilizing the copper radioisotope 64Cu for the diagnosis and treatment of intractable cancers, including innovative visible anti-cancer therapies.

Explore LinqMed, Inc's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in Japan